DEN220066 is the FDA 510(k) clearance record for BrainSee, a class II device, cleared for Darmiyan, Inc. on under FDA product code QWT (Prognostic Assessment Software Of Mild Cognitive Impairment). FDA's definition for product code QWT reads: "Prognostic assessment software of mild cognitive impairment. Prognostic assessment software of mild cognitive impairment is a prescription-only device that combines information from multiple clinical data sources to produce an output...". FDA records list one 510(k) clearance for Darmiyan, Inc. As of , FDA records show no recalls naming DEN220066.
Clearance record
- Decision date
- Received
- (469 days to decision)
- Product code
- QWT Prognostic Assessment Software Of Mild Cognitive Impairment
- Regulation
- 21 CFR 882.1454
- Device class
- Class II
- Review panel
- Neurology
- Applicant
- Darmiyan, Inc. 1425 Berkeley Way, Berkeley CA
- Third party review
- No
Clearances, product code QWT
Trailing 12 monthsFDA records hold no clearances under product code QWT in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
